CLSD - Clearside Biomedical, Inc.
0.8476
-0.012 -1.463%
Share volume: 52,173
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.86
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-10-2024 | 08-14-2023 | 11-13-2023 | 11-12-2024 | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 4.000 K | 1.018 M | 859.000 K | 6.345 M | 230.000 K | 90.000 K | 1.038 M | 306.000 K | |
| Cost of revenue | 0.000 | 213.000 K | 142.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 149.000 K | |
| Gross profit | 4.000 K | 805.000 K | 717.000 K | 6.345 M | 230.000 K | 90.000 K | 1.038 M | 157.000 K | |
| 20,025.00% | -10.93% | 784.94% | -96.38% | -60.87% | 1,053.33% | -84.87% | |||
| Operating expenses | 7.609 M | 8.075 M | 7.771 M | 9.260 M | 8.439 M | 7.680 M | 6.972 M | 7.306 M | |
| Selling general and admin | 3.158 M | 3.127 M | 2.637 M | 2.947 M | 2.824 M | 3.077 M | 2.844 M | 3.062 M | |
| Research and development | 4.451 M | 4.948 M | 5.134 M | 6.313 M | 5.615 M | 4.603 M | 4.128 M | 4.244 M | |
| Total expenses | 7.609 M | 8.075 M | 7.771 M | 9.260 M | 8.439 M | 7.680 M | 6.972 M | 7.306 M | |
| 6.12% | -3.76% | 19.16% | -8.87% | -8.99% | -9.22% | 4.79% | |||
| Operating income | -7.605 M | -7.270 M | -7.054 M | -2.915 M | -8.209 M | -7.590 M | -5.934 M | -7.149 M | |
| Ebit | -7.605 M | -7.270 M | -7.054 M | -2.915 M | -8.209 M | -7.591 M | -5.934 M | -7.149 M | |
| Pretax income | -9.280 M | -9.106 M | -9.267 M | -6.142 M | -10.264 M | -9.512 M | -8.053 M | -9.370 M | |
| -1.88% | 1.77% | -33.72% | 67.11% | -7.33% | -15.34% | 16.35% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -9.280 M | -9.106 M | -9.267 M | -4.832 M | -11.763 M | -7.594 M | -7.688 M | -7.307 M | |
| 1.88% | -1.77% | 47.86% | -143.44% | 35.44% | -1.24% | 4.96% |
